Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Fredric N. Eshelman
Age : 72
Public asset : 10,890,329 USD
Linked companies : Aravive, Inc. - Amplitude Healthcare Acquisition Corporation - Eyenovia, Inc.
Summary 
Founder of PPD, Inc., Pharmaceutical Product Development LLC and Eshelman Ventures LLC, Fredric N. Eshelman is an entrepreneur and businessperson who has been at the head of 8 different companies and presently holds the position of Chairman at Cellective BioTherapy, Inc., Chairman for Eyenovia, Inc., Chairman of Aravive, Inc. and Chief Executive Officer & Director at Innocrin Pharmaceuticals Holdings LLC. Fredric N. Eshelman is also on the board of 7 other companies.

In his past career he was Chief Executive Officer & Director at Innocrin Pharmaceuticals, Inc., Director at Accelerator Services Corp., Principal at Boehringer Mannheim Pharmaceuticals Corp., Executive Chairman at Pharmaceutical Product Development LLC, Executive Chairman of The Medicines Co., Chairman for Furiex Pharmaceuticals, Inc., Director & Senior Vice President-Development at Glaxo, Inc., Trustee at The University of North Carolina at Wilmington and Owner at Harvard Business School.

Fredric N. Eshelman received a doctorate from the University of Cincinnati (Ohio) and an undergraduate degree from The University of North Carolina at Chapel Hill.


Current positions of Fredric N. Eshelman 
NameTitle Since
Aravive, Inc.
(Biotechnology & Medical Research)
Chairman -
Amplitude Healthcare Acquisition Corporation
(Investment Holding Companies)
Independent Director 2019
Eyenovia, Inc.
(Pharmaceuticals)
Chairman 2018
Dignify Therapeutics LLC Director -
Innocrin Pharmaceuticals Holdings LLC Chief Executive Officer & Director -
Aton Pharma, Inc. Director -
North Carolina School of Science & Mathematics Member-Governors Board -
University of North Carolina System Member-Governors Board -
Cellective BioTherapy, Inc. Chairman -
Aero MD Director -
Asepticys LLC Director 2018
Eshelman Ventures LLC Founder -


Holdings of Fredric N. Eshelman 
NameEquities%Valuation
Eyenovia, Inc. (EYEN)
(Pharmaceuticals)
1,292,7874.98%7,110,329 USD
G1 Therapeutics, Inc. (GTHX)
(Biotechnology & Medical Research)
250,0000.59%3,780,000 USD


Fredric N. Eshelman: Personal Network 
Most Read News 
09/07GEORGE SOROS : Soros says BlackRock's China investments likely to lose money - WSJ
RE
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
RE
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
RE
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
RE
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
09/08MICHAEL O'LEARY : Exclusive-Ryanair ready to wait years for Boeing to cut prices, says O'Leary
RE
More news


© 2021 People and Ownership :   
Fredric N. Eshelman : Connections